Малые повреждения миокарда при плановом стентировании коронарных артерий сердца
Диссертация
Учитывая, что использование методов анализа тропонина Т для выявления наличия в крови кардиального тропонина Т позволило существенно повысить специфичность, чувствительность и надежность при диагностике повреждения миокарда у пациентов с ОКС, нами впервые в России была предпринята попытка расширить область применения тропонина Т v категории пациентов с хроническими формами ИБС. которым… Читать ещё >
Список литературы
- Adams JR, Bodor GS, Davi la-Roman VG, et al Cardiac troponin I, A marker with high specificity for cardiac injury-Circulation 1993,88:101−106.
- EJertinchant JP, Larue C, Pemel I. eial. Release kinetics of scrum cardiac troponin I in ischemic myocardial injury. CI inBiochem 1996−29:684−694.
- Mair J, Genser N, Morandell D. ct al. Cardiac troponin I in the diagnosis of myocardial injury and infarctron. Clm ChimActa 1996−245:19−38.
- Ravkilde J, Nissen H+ Mickley H, etaJ. Cardiac troponin T and CK-MB mass release after visually success fulpcrcutaneous transluminal coronary angioplasty in stable angina pectoris, Am Heart J 1994−127:13−20.
- Abbas SA, Glazier Jt WU AHB, el al. Factors associated with the release of cardiac troponin T following percutaneoustransluminal coronary angioplasty Clin Cardiol 1996- 19:782−786.
- ANelmeguid A, Topol E, Whitlow P, eial. Significance of mild transient release of creatine kinase-MB fraction afterpercuianeous coronary interventionsCirculation 1996,94- S 528−1536.
- Kong T. Davidson С Meyers S, et aJ. Prognostie implication of creatine kinase elevation following elective coronaryartery interventions. J Am Med Assoc 1997−277:461−466,
- Smith Sc, Jr. Dove JT, Jacobs AK, etal. ACC/AHA guidelines foe-percutaneous coronary intervention: A report ofAmerican College of Cardiology/American Heart Association Task Force on PracticeGuidelines
- KiJjrr JR, Muttrej MR, Matthai WH, etal. Role of cardiac troponin T in the long4erm risk stratification of patienisundcrgoing percutancos coronary intervention. Eur HeartJ2003−24:1314−1322.
- Cantor WJ, Newby l-K, Christenson RH, et al. The SYMPHONY and 2nd SYMPHONY Cardiac Markers SubstudyJnvestigatorsPrognosiic significance of elevated troponin I after pcrcutaneouscoronary intervention. J Am CollCardiol2002−39:l 738−1744.
- Fuchs S, Grubcrg L, Singh S, ct al. Prognostic vafue of cardiac troponin f re-etevation following percutaneouscoronary intervention in high-risk patients with acute coronary syndromes. Am JCardiol2001−88:129—133,
- Garbaz E, Lung B, Lefcvre G, et al. Frequency and prognostic value of cardiac troponin 1 elevation after coronarystenting. Am JCardiol I999−84:515−518.
- Attali P, Alteil B, Pettpas G, et al. Sensitivity and long-term prognostic value of cardiac troponin-! increaseshortly after percutaneous transluminal coronary ang topi asly. C) tnCardi ol 1998−21:353−356.
- Rucker CM, Dugall JC+ Ganter EL, et al. The detection of perioperative myocardial infarction in aortocororiary bypass surgery. Chest 1979−75:3QQ.
- K1ein LW, Kramer BL, Howard Ё, et al. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty, J Am Coll Cardiol 1991−17:621−6.
- Oil JK, Shub C, llstrup DM, et al- Creatine kinase release after successful percutaneous transluminal coronary angioplasty. Am Heart J 1985- 109:122 531.
- Pauletio P, Piccolo D, Scannapieco G, et al. Changes in myoglobin, creatine kinase and creatine kinase-MB after percutaneous transluminal coronary angioplasty for stable angina pectoris. Am J Cardiol 1987−59:999−1000.
- К u gel mass AD, Cohen DJ, Moscucci M, ct al, Elevation of the creatine kinase myocardial isoform following otherwise successful directional atherectomy and stcnting. Am J Cardiol 1994−74:748−54.
- AbdcImeguid AE. Ellis SG, Sapp SK, et al. Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions. Am Heart J 1996−131:1097−2015.
- Simoons ML, Harrington RA, Anderson KM, et al. Small non-Q wave infarctions during PTCA are associated with increased 6 months' mortality abstract., Circulation 1997−96:1−30.
- Katm HA, Remppis A, Neumann FJ, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991−83:902−12.
- Hamm CW, Ravkilde I, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992−327:146−50.
- Amman EM, Tanasijevic MJ, Thompson B, et al, Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Eng J Med 1996−335:1342−9.
- Newby LK, Christervson RH, Ohman EM, et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronaiy syndromes, The GUSTO-lla Investigators. Circulation 1998−98:1853−9.
- Whitlow PL, Topol EJ, Abdclmeguid AE, et al. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 1997−94:1528−36.
- Karim MA, Shinn M, Oskarsson H+ et al. Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty, Am J Cardiol 1995−76:521−3.
- Glazier JJ. Wu AH, et al. Factors associated with the release of cardiac troponin T and I following percutaneous transluminal coronary angioplasty and stenting. Clin Cardiol 1997−19:782−6,
- Alia.i P, Aleil B, Pethpas GT et al. Sensitivity and long-term prognostic value of cardiac troponin 1 increase shortly after percutaneous transluminal coronary angioplasty. Clin Cardiol 1998−21:353−6.
- Wu AH. Feng YJ, Contois JH, et al. Comparison of myoglobin, creatine kinase-MB, and cardiac troponin 1 for diagnosis of acute myocardial infarction. Ann Clin Lab Sci 1996−26:291−300.
- ЗЙ-TardjfT BE. CalifT RM. Tcheng JE, et at. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention: IMPACT-II Investigators. J Am Coll Cardiol 1999−33:88−96.
- Fuchs S, Komowski R, Mehran R, et al. Prognostic value of cardiac troponin-J levels following catheter-based coronary interventions, Am J Cardiol 2000−85:1077−82.
- Bertinchant JP, Polgc A, Ledermann B, et al. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol 1999−84:51−7.
- Dixon SH Jr, Limbird LE, Roe CR* el al. Recognition of postoperative acute myocardial infarction. Application of isoenzyme techniques. Circulation 1973−48(3 Suppl}:HM37.
- Rucker CM, DugaH JC, Gamer EL, cl al. The detection of perioperative myocardial infarction in aortocoronary bypass surgejy. Chest 1979−75:300,
- Scannapieco G, Pauletto P" Piccolo D, et at. Changes in myoglobin, creatine kinase and creatine kinase-MB after percutaneous transluminal coronary angioplasty for stable angina pectoris. Am J Cardiol 1987−59:999−1000.
- Davidson CJ, Kong TQ el al. Prognostic implication of creatine kinase elevation following elective coronary artery interventions, JAMA 1998−264:322−6.
- Dangas G, Hong MK, Mehran R, et al. Creatine kinase-MB enzyme elevation following successful vein graft intervention in associated with late mortality. Circulation 1999−100:2400−5.
- Gerhardi W, Hamm CWt Ravkilde J, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992−327: 46−50.
- Tanasijevic M J, Antman EM, Thompson B, et a., Cardiac-specific troponin 1 levels to predict the risk of mortality in patients with acute coronary syndromes. N Eng J Med 1996−335:1342−9.
- Christenson RH, SM. Saadeddin, Ncwby LK,, Ohman EM. et at. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-Ila Investigators. Circulation 1998−98:1853−9.
- Whitlow PL, Topol EJ et al. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 1999−94:1427−32.
- Ravkilde J, Nissen H, Mickley H, et al. Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronaiy angioplasty in stable angina pectoris. Am 1 lean J 1994−127:13−20.
- Pelitpas G, Aleil В et al. Sensitivity and long-term prognostic value of cardiac troponin I increase shortly after percutaneous transluminal coronary angioplasty. Clin Cardiol 2000−22:467−9.
- Marker LA, E. Garbarz Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. Am J Cardiol 1987−60:20B-28B.
- Golino P, Willerson JT, Eidt J. Specific platelet mediators and unstable coronary artery lesions: experimental evidence and potential clinical implications. Circulation 1989−80:198−205.
- Ricciardi MJ, Harrington RA. Platelet inhibition in cardiovascular disease management: aspirin and beyond, JThromb Thrombolysis 1998−5:37−41.
- Gruntzig AR, Myler RK, Hanna ES, Transluminal angioplasty of coronary artery stenosis. Circulation 1977−56:84,
- Coller BS, Shyu KG. A new murine monoclonal antibody reports ал activation-dependent change in the conformation and/or microenvironmem of the glycoprotein llb/llla complex. J CFin Invest I985−76:101−108.
- Cawthem KM, Butenas S, van’t Veer C. Antiplatelet agents in tissue factor-induced blood coagulation, Blood 2001−97:2314−2322.
- Thcroux P, Timuricayrwk T, Waters D. Lam J, Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med 1992−327:141−145.
- Knight CJ, Panesar M, Wilson DJ. Increased platelet responsiveness following coronary stenting: heparin as a possible etiological factor in stent thrombosis. Eur Heart J 1998- 19:1239−1248.
- Xiao Z. Theroux P, Platelet activation with unfract ionatcd heparin at therapeutic concentrations and comparisons with a low-molecular-wetght heparin and with a direct thrombin inhibitor. Circulation 1998−97:251−256.
- Ashby DT, Dangas Gt Aymong EA. Relation between the degree of procedural anticoagulation and complications after coronary stent implantation. Am J Cardiol 2003−92:319−322.
- Brieger DB, Мак KM, Kottke-Marchant K. Hcparin-induced thrombocytopenia, J Am Coll Cardiol 1998−31:1449−1459.
- Sl.Narins CR, Hillegass WB, Nelson CL. Relationship between activated clotting time during angioplasty and abrupt closure. Circulation 1996−93:667−671.
- CyShea JC, Hafley GE. Grccnberg S. Platelet glycoprotein ПЬЛИа imegrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial. JAMA 2001−285:2468−2473.
- Gildirist ГС. О1 Shea /С, Kosogfou T, Pharmacodynamics arid pharmacokinetics of higher-dose. double-bolus eptifibatide in percutaneous coronary intervention. Circulation 2001−104:406−411.
- EPIC Investigators. Use оГ a monoclonal antibody directed against the platelet glycoprotein Ilh/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994−330:956−961.
- EPILOG Investigators. Platelet glycoprotein ПМНа receptor blockade and low dose heparin during percutaneous coronary revascularisation. N EngJ J Med 1997:336:1689−1696.
- CAPTURE Investigators. Randomized placebo-controlled trial of abciximab before, during and after coronary intervention in refractory unstable angina: the CAPTURE study. Lancet 1997−349:1429−1435.
- EPISTENT Investigators, Randomized placebo-control led and balloon-angioplasty-controlled trial to assess safely of coronary stenting with use of platelet glycoprotein Ilb/Illa blockade. Lancet 1998−352:87−92.
- Stone GW, Molitemo DJ, Bertrand M. Impact of clinical syndrome acuity on the differential response to 2 glycoprotein Jlb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET trial. Circulation 2002−105:2347−2354.
- Mehta SR. Yusuf S, Peters RJG. Effects of prctreatmeru with clopidogrel and aspirin followed by long term therapy in patients undergoing percutaneous coronary intervention: the PCT-CURE study, Uncet 2001−358:527−533.
- Boccara A. Benamer J-M, Juliard P. A randomized trial of a fixed high dose vs. a weight-adjusted low dose of intravenous heparin during coronary angioplasty. Eur Heart J 1997- 18:631 -635.
- Koch KT, Pick J., dc Winter RJ. Safety of tow dose heparin in elective angioplasty. Heart 1997−77:517−522.
- I>enardo SJ. Davis K?, Reid PR. Efficacy and safety of minima! dose (< 1000 units) un fractionated heparin with abciximab in percutaneous coronary intervention. Am J Cardiol 2003−91:1−5,
- Belmont Report: ethical principles and guidelines for the protection of human subjects of research. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, Fed Regist 1979−44:2 319 223 197.
- Preventionof venous thromboembolism: international consensus stalemcntfguidelines according to clinical evidence). Int Angiol 16- 1997:3−38.
- GlantzSA. Primer of biostatistics. New York: McGraw-Hill- 1992, Chapter7.
- Islam MA* Blankenship JC, Balog C, Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet Ub/llla Inhibition in Stenting Trial (EPISTENT). Am J Cardiol 2002−90:916−921.
- Tolleson TR. 0"Shea JC, Bittl J A, Relationship between heparin anticoagulation and clinical outcomes in coronary' stent intervention: observations from the ESPRIT trial. J Am Coll Cardiol 2003−41:386−393.
- Ray JG. Evidence in upheaval. Incorporating observational data into clinical practice. Arch Inlem Med 2002- 162:249−254
- Бабунашвнли A.M., Иванов В. А. Бирюков С.А. Эндопротездро-ванне (стентироваине) венечных артерий сердца. М., 2001 — 600−620,
- Боксркя JIA-, Алекян Б. Г., Коломбо, А. Буздашвили ЮН Интервенционные методы лечения ншемнческой болезни сердца. М.: Издательство НЦСХХ им. А, Н. Бакулева РАМН" 2002.-417−420.
- Feng YJ, Chen С, Fallon JT, ei al. Comparison of cardiac troponin I. creatine kinase-MB, and myoglobin for detection of acute ischemic myocardial injury is a swine model. Am J Clin Pathol 1998−110:70−77.
- Lefevre G, Garbar/ E, lung B, et al. Frequency and prognostic value of cardiac troponin 1 elevation after coronary stenting. Am J Cardiol 83:515−518,
- Ferns GA, Sobki SH, Minor myocardial injury after elective uncomplicated successful PTCA with or without stenting: Detection by cardiac troponins, Cathet Cardiovasc Intervcnt 2004−53:178−186,
- EPIC Investigators. Use of a monoclonal antibody directed against the plaleJei glycoprotein Jlb/JIJa receptors in high-risk coronary angioplasty. N Engl J Med 1994−330:956−961.
- Hamon M. Richardeau Y, Lecluse E, et al. Direct coronary stenting without balloon prcdiiation in acute coronary syndromes. Am Heart J 1999−138:55−59.
- Gibson CM, de Lemos J A, Murphy SA, et al., for the TIMI Study Group Combination therapy with abciximab reduces angiographicalJy evident thrombus in acute myocardial infarction: A TIMI 14 substudy. Circulation 2001- 103:2550−2554.
- Briguori CT Sheiban I, De Gregorio J, et al. Direct coronary stcnting without prediction. 1 Am Coll Cardiol 1999−34−191(M9I5.
- Here I. Assali A" Solodky A, el al. Effectiveness of coronary stent deployment without predilaiion. Am J Cardiol 1999−84:89−91.
- Rogers C, Parikh S, Seifert P. Edelman E. Endothelial cell seeding: Remnant endothelium after stenting enhances vascular repair. Circulation 199"-94−2909−29I4,
- Webb J, Carere R, Virmani R. et al. Retrieval and analysis of particulate debris following saphenous vein graft intervention. J Am Cotl Cardiol 1999−34:468−475.